Transgenic Cell Line Pyrogen Detection via Toll-Like Receptors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting pathogens and pyrogens in sepsis patients are time-consuming, unreliable, and often fail to identify the specific spectrum of pathogens, leading to delayed and ineffective treatment, with existing tests being costly, requiring specialized equipment, and involving animal suffering or limited sensitivity.
Innovation Solution
A transgenic cell line expressing human Toll-like receptors (TLR-2 and TLR-4) with a reporter gene under NF-κB-inducible promoter, capable of detecting pyrogens and pathogen-associated microbial patterns (PAMPs) with high sensitivity and selectivity, allowing for rapid and simple identification of pathogens in clinical samples without the need for complex laboratory equipment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional pathogen detection methods (cultivation experiments) are used, then the probability of detecting pathogens is 30 to 50%, but the detection time is prolonged and the method fails to identify pathogens when samples are taken during antibiotic therapy
Solution Approach 1:
The patent replaces the mechanical cultivation-based detection system with a biological detection system using transgenic cells expressing Toll-like receptors. These cells directly detect pyrogenic substances and PAMPs through molecular recognition, eliminating the need for time-consuming pathogen cultivation and enabling detection even when pathogens are suppressed by antibiotic therapy
Solution Approach 2:
The patent introduces transgenic indicator cells as an intermediary between the pathogen and the detection system. These cells express Toll-like receptors that recognize pyrogenic substances and PAMPs, converting the presence of pathogens into a measurable signal through reporter gene expression, thereby enabling indirect but rapid detection without direct pathogen cultivation
2Reliability
If rabbit pyrogen test is used, then pyrogenic substances can be detected, but the test is time-consuming, costly, and involves animal suffering
Solution Approach 1:
The patent uses transgenic indicator cells that can be cultured in vitro and disposed of after a single test, replacing the need for live rabbits. These cells provide a simplified, animal-free system that reduces both ethical concerns and operational complexity while maintaining pyrogen detection capability
Solution Approach 2:
The patent replaces the complex animal-based physiological response system with a simplified cellular assay system. The transgenic cells directly respond to pyrogens through Toll-like receptor activation and reporter gene expression, eliminating the need for monitoring animal fever responses and reducing overall system complexity
3Measurement precision
If Limulus Amebocyte Lysate Test is used, then endotoxins from gram-negative bacteria can be detected quantitatively, but the test cannot detect pyrogens from gram-positive bacteria or other microorganisms
Solution Approach 1:
The patent creates a universal detection system using transgenic cells that can detect multiple types of pyrogenic substances and PAMPs from various microorganisms including gram-negative bacteria, gram-positive bacteria, fungi, and viruses. The system maintains high sensitivity for endotoxins while expanding detection capability to a broad pathogen spectrum through the use of different Toll-like receptors
Solution Approach 2:
The patent employs composite cellular systems expressing different Toll-like receptors (TLR2, TLR4, etc.) to create a multi-functional detection platform. Each TLR targets specific pathogen patterns, and their combination in a single cell line enables simultaneous detection of diverse pyrogenic substances with high precision and broad versatility
4Reliability
If multiple cultures are created for microbiological examinations, then the probability of pathogen detection increases to 30 to 50%, but the cost and time requirements increase significantly
Solution Approach 1:
The patent merges multiple detection capabilities into a single transgenic cell line that simultaneously expresses multiple Toll-like receptors. This allows one test to replace multiple separate cultures and examinations, maintaining high pathogen identification accuracy while dramatically improving detection throughput and reducing time requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The transgenic cell line enables specific and sensitive detection of pyrogens and PAMPs, facilitating early and targeted treatment of sepsis patients, with sensitivity improved to 1-10 pg/ml LPS, compared to conventional methods, and allowing for the use in various clinical and industrial applications.
Implementation Method 1
The cell line expresses human Toll-like receptors (TLR-2 and TLR-4) with a reporter gene under NF-κB-inducible promoter, capable of detecting pyrogens and pathogen-associated microbial patterns (PAMPs)
Implementation Method 2
a transgenic cell line expressing human Toll-like receptors (TLR-2 and TLR-4) with a reporter gene under NF-κB-inducible promoter
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to methods, agents and kits for the qualitative and quantitative assay and identification of pathogenes and pathogenic spectra, based on endotoxins and other pyrogenes.